BIOAVAILABILITY AND ACCEPTABILITY OF A DISPERSIBLE FORMULATION OF LEVODOPA-BENSERAZIDE IN PARKINSONIAN-PATIENTS WITH AND WITHOUT DYSPHAGIA

被引:25
|
作者
BAYER, AJ
DAY, JJ
FINUCANE, P
PATHY, MSJ
机构
关键词
D O I
10.1111/j.1365-2710.1988.tb00179.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:191 / 194
页数:4
相关论文
共 50 条
  • [21] A QUANTITATIVE STUDY OF THE ELECTROENCEPHALOGRAPHIC RESPONSE TO LEVODOPA TREATMENT IN PARKINSONIAN-PATIENTS
    YAAR, I
    SHAPIRO, MB
    CLINICAL ELECTROENCEPHALOGRAPHY, 1983, 14 (02): : 82 - 85
  • [22] ELECTROENCEPHALOGRAPHIC CHANGE IN PARKINSONIAN-PATIENTS TREATED WITH LEVODOPA-CARBIDOPA
    STEPHENS, R
    GREEN, J
    HAYCOOK, W
    KILGORE, M
    CLINICAL ELECTROENCEPHALOGRAPHY, 1979, 10 (01): : 31 - 34
  • [23] SUSTAINED-RELEASE LEVODOPA IN PARKINSONIAN-PATIENTS WITH NOCTURNAL DISABILITIES
    VANDENKERCHOVE, M
    JACQUY, J
    GONCE, M
    DEDEYN, PP
    ACTA NEUROLOGICA BELGICA, 1993, 93 (01) : 32 - 39
  • [24] THE EFFECT OF LEVODOPA TREATMENT ON THE VISUAL EVOKED-POTENTIALS IN PARKINSONIAN-PATIENTS
    YAAR, I
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1980, 50 (3-4): : 267 - 274
  • [25] RELEVANCE OF PHARMACOKINETIC HANDLING TO TERMINATION OF EFFECT OF LEVODOPA IN ELDERLY PARKINSONIAN-PATIENTS
    BOWES, SG
    ONEILL, CJA
    DESHMUKH, AA
    LEEMAN, AL
    DOBBS, SM
    DOBBS, RJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (01) : P123 - P124
  • [26] PERIPHERAL PHARMACOKINETIC PARAMETERS OF LEVODOPA CARBIDOPA AND THE ON-OFF PHENOMENON IN PARKINSONIAN-PATIENTS
    RAINERO, I
    GILLI, M
    DEGENNARO, T
    CHIADO, I
    DELSEDIME, M
    RICCIO, A
    BERGAMASCO, B
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1988, 9 (03): : 225 - 259
  • [27] INCREASE IN REM-SLEEP OCULAR ACTIVITY IN PARKINSONIAN-PATIENTS TREATED WITH LEVODOPA
    LAVIE, P
    BENTAL, E
    GOSHEN, H
    SHARF, B
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1979, 15 (03): : 292 - 292
  • [28] EFFECTS OF SUSTAINED DEPRENYL AND TOCOPHEROL THERAPY IN LEVODOPA-TREATED PARKINSONIAN-PATIENTS
    PENNEY, JB
    ANNALS OF NEUROLOGY, 1993, 34 (02) : 247 - 247
  • [29] An acute and long-term study with a dispersible formulation of levodopa/benserazide (Madopar(R)) in Parkinson's disease
    Monge, A
    Barbato, L
    Nordera, G
    Stocchi, F
    EUROPEAN JOURNAL OF NEUROLOGY, 1997, 4 (05) : 485 - 490
  • [30] EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON CLINICAL DISABILITY AND LEVODOPA METABOLISM IN PARKINSONIAN-PATIENTS
    KAAKKOLA, S
    TERAVAINEN, H
    AHTILA, S
    RITA, H
    GORDIN, A
    NEUROLOGY, 1994, 44 (01) : 77 - 80